A T Cell-Inducing Influenza Vaccine for the Elderly: Safety and Immunogenicity of MVA-NP+M1 in Adults Aged over 50 Years

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Antrobus, Richard D ^a   Lillie, Patrick J ^a   Berthoud, Tamara K ^a   Spencer, Alexandra J ^a   McLaren, James E ^b   Ladell, Kristin ^b   Lambe, Teresa ^a   Milicic, Anita ^a   Price, David A ^b   Hill, Adrian V S ^a   Gilbert, Sarah C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD45RO ANTIGEN; CD57 ANTIGEN; CHEMOKINE RECEPTOR CCR7; GAMMA INTERFERON; INFLUENZA VACCINE; MODIFIED VACCINIA VIRUS ANKARA NUCLEOPROTEIN PLUS MATRIX PROTEIN 1 VACCINE; UNCLASSIFIED DRUG; VIRUS VECTOR;

ABDOMINAL PAIN; ADULT; AGE DISTRIBUTION; AGED; ARTHRALGIA; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CONTROLLED STUDY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; ELDERLY CARE; ENZYME LINKED IMMUNOSPOT ASSAY; ERYTHEMA; FATIGUE; FEMALE; FEVER; FLOW CYTOMETRY; GENE EXPRESSION; HEAT; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; LETHARGY; MALAISE; MALE; MEMORY T LYMPHOCYTE; MOLECULAR CLONING; MYALGIA; NAUSEA; NONHUMAN; PAIN; PHASE 1 CLINICAL TRIAL; PHENOTYPE; PRURITUS; SIDE EFFECT; SWELLING; TCR GENE; VIRUS GENE;

AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; FEMALE; HUMANS; INFLUENZA A VIRUS, H3N2 SUBTYPE; INTERFERON-GAMMA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NUCLEOPROTEINS; ORTHOMYXOVIRIDAE; SAFETY; T-LYMPHOCYTES; VACCINIA VIRUS; VIRAL PROTEINS; VIRAL VACCINES;

EID: 84868283459     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0048322     Document Type: Article

References (29)

1. Hardelid P, Pebody R, Andrews N (2012) Mortality caused by influenza and respiratory syncytial virus by age group in England and Wales 1999-2010. Influenza Other Respi Viruses.
2. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA, (2007) Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 7: 658-666.
3. Nicholson KG, Wood JM, Zambon M, (2003) Influenza. Lancet 362: 1733-1745.
4. Goodwin K, Viboud C, Simonsen L, (2006) Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine 24: 1159-1169.
5. Osterholm MT, Kelley NS, Sommer A, Belongia EA, (2012) Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 12: 36-44.
6. Olsson J, Wikby A, Johansson B, Löfgren S, Nilsson BO, et al. (2000) Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 121: 187-201.
7. Sambhara S, McElhaney JE, (2009) Immunosenescence and influenza vaccine efficacy. Curr Top Microbiol Immunol 333: 413-429.
8. Lambert LC, Fauci AS, (2010) Influenza vaccines for the future. N Engl J Med 363: 2036-2044.
9. Gilbert SC, (2012) T-cell-inducing vaccines- what's the future. Immunology 135: 19-26.
10. Sutter G, Moss B, (1992) Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proc Natl Acad Sci U S A 89: 10847-10851.
11. Berthoud TK, Hamill M, Lillie PJ, Hwenda L, Collins KA, et al. (2011) Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1. Clin Infect Dis 52: 1-7.
12. Lillie PJ, Berthoud TK, Powell TJ, Lambe T, Mullarkey C, et al. (2012) A preliminary assessment of the efficacy of a T cell-based influenza vaccine, MVA-NP+M1, in humans. Clin Infect Dis.
13. Berthoud TK, Fletcher H, Porter D, Thompson F, Hill AV, et al. (2009) Comparing human T cell and NK cell responses in viral-based malaria vaccine trials. Vaccine 28: 21-27.
14. Price DA, Brenchley JM, Ruff LE, Betts MR, Hill BJ, et al. (2005) Avidity for antigen shapes clonal dominance in CD8+ T cell populations specific for persistent DNA viruses. J Exp Med 202: 1349-1361.
15. Quigley MF, Almeida JR, Price DA, Douek DC, (2011) Unbiased molecular analysis of T cell receptor expression using template-switch anchored RT-PCR. Curr Protoc Immunol Chapter 10: Unit10.33.
16. Lefranc MP, Pommié C, Ruiz M, Giudicelli V, Foulquier E, et al. (2003) IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. Dev Comp Immunol 27: 55-77.
17. McElhaney JE, Ewen C, Zhou X, Kane KP, Xie D, et al. (2009) Granzyme B: Correlates with protection and enhanced CTL response to influenza vaccination in older adults. Vaccine 27: 2418-2425.
18. Miles JJ, Douek DC, Price DA, (2011) Bias in the αβ T-cell repertoire: implications for disease pathogenesis and vaccination. Immunol Cell Biol 89: 375-387.
19. Moss PA, Moots RJ, Rosenberg WM, Rowland-Jones SJ, Bodmer HC, et al. (1991) Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc Natl Acad Sci U S A 88: 8987-8990.
20. Lehner PJ, Wang EC, Moss PA, Williams S, Platt K, et al. (1995) Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the V beta 17 gene segment. J Exp Med 181: 79-91.
21. Amato RJ, Hawkins RE, Kaufman HL, Thompson JA, Tomczak P, et al. (2010) Vaccination of metastatic renal cancer patients with MVA-5T4: a randomized, double-blind, placebo-controlled phase III study. Clin Cancer Res 16: 5539-5547.
22. Hannoun C, Megas F, Piercy J, (2004) Immunogenicity and protective efficacy of influenza vaccination. Virus Res 103: 133-138.
23. Targonski PV, Jacobson RM, Poland GA, (2007) Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine 25: 3066-3069.
24. Kannanganat S, Ibegbu C, Chennareddi L, Robinson HL, Amara RR, (2007) Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells. J Virol 81: 8468-8476.
25. Darrah PA, Patel DT, De Luca PM, Lindsay RW, Davey DF, et al. (2007) Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nature medicine 13: 843-850.
26. McElhaney JE, Zhou X, Talbot HK, Soethout E, Bleackley RC, et al. (2012) The unmet need in the elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines. Vaccine 30: 2060-2067.
27. Hendel A, Hiebert PR, Boivin WA, Williams SJ, Granville DJ, (2010) Granzymes in age-related cardiovascular and pulmonary diseases. Cell Death Differ 17: 596-606.
28. McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, et al. (2006) T cell responses are better correlates of vaccine protection in the elderly. J Immunol 176: 6333-6339.
29. Brenchley JM, Karandikar NJ, Betts MR, Ambrozak DR, Hill BJ, et al. (2003) Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T cells. Blood 101: 2711-2720.